Abstract
Quantitation of renal function may be performed with a variety of radiopharmaceuticals which reflect slightly different renal functions. Plasma sampling techniques and imaging techniques have been used to derive absolute measurements of renal function. The addition of imaging permits the determination of relative or “split” function. Time-activity curves from renal studies provide other quantitative parameters of function reflecting arterial supply, renal cortical function, and patency of the renal collecting system. Quantitative radionuclide studies of the kidneys provide comprehensive, reproducible, and objective assessments of renal function.
Similar content being viewed by others
References
Taylor AT: Quantitative renal function scanning: A historical and current status report on renal radiopharmaceuticals. In Freeman LM, Weissman HS (eds):Nuclear Medicine Annual 1980. New York: Raven Press, 1980, pp 303–340
Stadalnick RC, Vogel JM, Jansholt A-L,et al.: Renal clearance and extraction parameters of ortho-iodohippurate (I-123) compared with OIH (I-131) and PAH.J Nucl Med 21:168–170, 1980
McAfee JG, Grossman ZD, Gagne GR,et al.: Comparison of renal extraction efficiencies for radioactive agents in the normal dog.J Nucl Med 22:333–338, 1981
Eshima D, Taylor A Jr, Fritzberg AR,et al.: Animal evaluation of Tc-99m triamide mercaptide complexes as potential renal imaging agents.J Nucl Med 28:1180–1186, 1987
Taylor A, Eshima D: Effects of altered biochemical and physiologic states on the clearance and biodistribution of technetium-99m MAG3, iodine-131 OIH and iodine-125 iothalamate.J Nucl Med 29:669–675, 1988
Short MD, Glass HI, Chisholm GD, Vernon P, Sivester DJ: Gamma-camera renography using 123I-hippuran.Br J Radiol 46:289–294, 1973
Barbour GL, Crumb CK, Boyd CM, Reeves RD, Rastogi SP, Patterson RM: Comparison of inulin, iothalamate, and 99mTc-DTPA for measurement of glomerular filtration rate.J Nucl Med 17:317–320, 1976
Klopper JF, Hauser W, Atckins HL, Eckelman WC, Richards P: Evaluation of 99mTc-DTPA for the measurement of glomerular filtration rate.J Nucl Med 8:77–85, 1972
Nielsen SP, Møller ML, Trap-Jensen J: 99m Tc-DTPA scintillation camera renography: A new method for estimation of single kidney function.J Nucl Med 18:112–117, 1977
Stabin M. Taylor A, Eshima D, Wooter W: Radiation dosimetry for technetium-99m-MAG3, technetium-99m DTPA, and iodine-131-OIH based on human biodistribution studies.J Nucl Med 33:33–40, 1992
Davison A, Jones A, Orvig C, Sohn M: A new class of oxotechnetium (+5) chelate complexes containing a TcON2S2 core.Inorg Chem 20:1629–1632, 1979
Fritzberg AR, Klingensmith WS, Whitney WP, Kuni CC: Chemical and biological studies of Tc-99m N, N′-bis(mercaptoacetamido)ethylenediamine: A potential replacement for I-131 hippuran.J Nucl Med 22:258–263, 1981
Fritzberg AR, Kuni CC, Klingensmith WC, Stevens J, Whitney WP: Synthesis and biological evaluation of Tc-99m N,N′-bis (mercaptoacetyl) 2,3-diaminopropanoate: A potential replacement for I-131 o-iodohippurate.J Nucl Med 23:592–598, 1982
Fritzberg AR, Kasina S, Eshima D,et al.: Evaluation of a new Tc-99m renal imaging agent, Tc-99m mercaptoacetylglycine (MAG3) as a hippuran replacement.J Nucl Med 27:111–116, 1986
Taylor AT, Eshima D, Fritzberg AR,et al.: Comparison of iodine-131 OIH and technetium-99m MAG3 renal imaging in volunteers.J Nucl Med 27:795–803, 1986
Bubeck B, Brandau W, Dreikorn K,et al.: Clinical comparison of I-131 o-iodohippurate with Tc-99m Co2-DADS-A and Tc-99m MAG3 by simultaneous double tracer measurement.Nucl Compact 17:135–138, 1986
Al-Nahhas AA, Jafri RA, Britton KE,et al.: Clinical experience with99mTc-MAG3, mercaptoacetyltriglycine, and a comparison with99mTc-DTPA.Eur J Nucl Med 14:453–462, 1988
Taylor AT, Eshima D, Christian PE, Milton W: Evaluation of Tc-99m mercaptoacetyltriglycine in patients with impaired renal function.Radiology 162:365–370, 1987
DuCret RP, Boudreau RJ, Gonzalez R, Carpenter R, Tennison J, Kuni CC: Clinical efficacy of 99m technetium mercaptoacetylglycine kit formulatin in routine renal scintigraphy.J Urol 142:19–22, 1989
Taylor AT, Ziffer JA, Eshima D: Comparison of Tc-99m MAG3 and Tc-99m DTPA in renal transplant patients with impaired renal function.Clin Nucl Med 15:371–378, 1990
Arnold RW, Subramanian G, McAfie JG,et al.: Comparison of 99mTc complexes for renal imaging.J Nucl Med 16:357–367, 1975
Taylor AT, Lallone RL, Hogan PL: Optimal handling of dimercaptosuccinic acid for quantitative renal scanning.J Nucl Med 21:1190–1193, 1980
Kagan BA, Kay R, Wasnick RJ, Carty H: 99mTc-DMSA scanning to diagnose pyelonephritic scarring in children.Urology 21:641–644, 1983
Daly MJ, Jones W, Rudd TG, Tremann J: Differential renal function using technetium-99m dimercaptosuccinic acid (DMSA): In vitro correlation.J Nucl Med 20:63–66, 1979
McDougal WS, Flanigan RC: Renal functional recovery of the hydronephrotic kidney predicted before relief of obstruction.Invest Urol 18:440–442, 1981
Beekhuis H, van Luyk WHJ, Piers DA: Differential renal function using technetium-99m dimercaptosuccinic acid (DMSA), in vivo correlation [letter].J Nucl Med 20:898–899, 1979
Daly MJ, Milutnovic J, Rudd TG,et al.: The normal 99mTc-DMSA renal image.Radiology 128:701–704, 1978
Lee HB, Blaufox MD: Tc-99m glucoheptonate (GHA) renal uptake: Influence of biochemical and physiological factors [abstract].J Nucl Med 25:75, 1984
Vanlic-Razumenic N, Malaxevic M, Stafanovic L: Comparative chemical, biological and clinical studies of 99m Tc-glucoheptonate and 99m Tc-dimercaptosuccinate as used in renal scintigraphy.Nuklearmedizin 18:40–46, 1979
Ziessman HA, Balseiro J, Fahey FH, Vasshe T, Dubiansky V: 99mTc-glucoheptonate for quantitation of differential renal function.AJR 148:889–893, 1987
Hurwitz GA, Powe JE, Mattor AG, Reed RH, Dreedger AH, Rendak I, Hagendoom P: Differential renal uptake of 201TL: Requirements for acquisition, display and quantification.Nucl Med Commun 12:885–899, 1991
Taylor A Jr, Ziffer JA, Steves A, Eshima D, Delaney VB, Welchel JD: Clinical comparison of I-131 orthoiodohippurate and the kit formulation of Tc-99m mercaptoacetyltriglycine.J Nucl Med 170:121–125, 1989
Garnett ES, Parsons V, Verall N: Measurement of glomerular filtration-rate in man using a51Cr/edetic-acid complex.Lancet 1:818–819, 1967
Burbank MK, Tauxe WN, Maher FT, Hunt JC: Evaluation of radioiodinated hippuran for the estimation of renal plasma flow.Proc Staff Meet Mayo Clin 36:372–386, 1961
Tauxe WN, Dubovsky EV, Kidd T Jr., Diaz F, Smith L: New formulas for the calculation of effective renal plasma flow.Eur J Nucl Med 7:51–54, 1982
Sapirstein LA: Volume of distribution and clearance of intravenously injected creatinine in the dog.Am J Physiol 181:330–335, 1955
Balachandran S, Toguri AG, Petrusick TW, Abbott LC: Comparative evaluation of quantitative glomerular filtration rate measured by isotopic and nonisotopic methods.Clin Nucl Med 6:150–153, 1981
Smart R, Trew P, Burke J, Lyons N: Simplified estimation of glomerular filtration rate and effective renal plasma flow.Eur J Nucl Med 6:249–253, 1981
Russell CD, Taylor A, Eshima D: Estimation of technetium-99m-MAG3 plasma clearance in adults from one or two blood samples.J Nucl Med 30:1955–1959, 1989
Russell CD, Dubovsky EV, Scott JW: Estimation of ERPF in adults from plasma clearance of I-131-hippuran using a single injection and one or two blood samples.Nucl Med Biol 16:381–383, 1989
Taylor AT, Ziffer JA, Steves A, Eshima D, Delaney VB, Welchel JD: Clinical comparison of131I orthoiodohippurate and the kit formation of Tc-99m mercaptoacetyltriglycine.Radiology 170:721–725, 1989
Russell CD, Bischoff PG, Kontzen F,et al.: Measurement of glomerular filtration rate by the single injection method plasma clearance with urein collection: A comparison of single sample, double sample, and multiple sample methods using Tc-99m-DTPA and Yb-169-DTPA.J Nucl Med 26:1243–1247, 1985
Gates GF: Glomerular filtration rate: Estimation from fractional renal accumulation of99mTc-DTPA (stannous).AJR 138:565–570, 1982
Tonnesen KH, Munck O, Hald T, Mogensen P, Wolf H: Influence on the renogram of variation in skin to kidney distance and the clinical importance thereof. Presented at the International Symposium on Radionuclides in Nephrology. Berlin, April 1974 (cited by Schlegel JU, Hamway SA: Individual renal plasma flow determination in 2 minutes.J Urol 116:282–285, 1976)
Enlander D, Weber PM, Dos Remedios LV: Renal cortical imaging in 35 patients: Superior quality with 99mTc-DMSA.J Nucl Med 15:743–749, 1975
Daly MJ, Jones W, Rudd TG, Tremann J: Differential renal function using technetium-99m dimercaptosuccinic acid (DMSA): In vitro correlation.J Nucl Med 20:63–66, 1979
Taylor A Jr, Lallone RL, Hagan PL: Optimal handling of dimercaptosuccinic acid for quantitative renal scanning.J Nucl Med 21:1190–1193, 1980
Kawamura J, Hosokawa S, Yoshida O: Renal function studies using99mTc-dimercaptosuccinic acid.Clin Nucl Med 4:39–46, 1979
Tauxe WN, Burke EC: Kidney depth and isotope renography.J Nucl Med 9:225, 1968
Gordon I, Anderson PJ, Orton M, Evans K: Estimation of technetium-99m-MAG3 renal clearance in children: Two gamma camera techniques compared with multiple plasma samples.J Nucl Med 32:1704–1708, 1991
Rutland MD: A comprehensive analysis of renal DTPA studies. Theory and normal values.Nucl Med Commun 6:11–20, 1985
Gordon I, Evans K, Peters AM, Kelly J, Morales BN, Goldraich N, Yau A: The quantitation of99mTc-DMSA in pediatrics.Nucl Med Commun 8:661–670, 1987
Russell CD, Thorstad BL, Stutzman ME, Yester MV, Fowler D, Dubovsky EV: The kidney: Imaging with Tc-99m mercaptoacetyl trylycine, a technetium labeled analog of iodohippurate.Radiology 172:427–430, 1989
Fill H, Spielberger M, Leidlmair K, Klima G: Nephrography with radioactive hippuran in transplanted kidneys: Interpretation, limitations, usefulness.Eur J Nucl Med 11:171–178, 1985
Britton K: Radionuclides in renal imaging.Br J Hosp Med 27:140–146, 1978
Ford K, Harris CC, Coleman RE, Dunnick NR: The radionuclide renogram as a predictor of relative renal blood flow.Radiology 149:819–821, 1983
Secker-Walker RH, Coleman RE: Estimating relative renal function.J Urol 115:621–625, 1976
Taplin, GV, Dore EK, Johnson DE: The quantitative radiorenogram for total and differential renal blood flow measurement.J Nucl Med 4:404, 1963
Bueschen AJ, Lloyd LK, Dubovsky EV, Tauxe WN: Radionuclide kidney function evaluation in the management of urolithiasis.J Urol 120:16–20, 1978
Macleod MA, Houston AS: A comparison of three methods of assessing renal function.Eur J Nucl Med 6:183–189, 1981
Kainer G, McIlveen B, Höschl R, Rosenberg AR: Assessment of individual renal function in children using 99m Tc-DTPA.Arch Dis Child 54:931–936, 1979
Diffey BL, Hall FM, Corfield JR: The 99m TcDTPA dynamic renal scan with deconvolution analysis.J Nucl Med 17:352–355, 1976
Kenny RW, Ackery DM, Fleming JS,et al.: Deconvolution analysis of the scintillation camera renogram.Br J Radiol 48:481–486, 1975
Buck AC, Macleod MA, Blacklock NJ: The advantages of 99m Tc DTPA(Sn) in dynamic renal scintigraphy and measurement of renal function.Br J Urol 52:174–186, 1980
Britton KE, Nimmon CC, Whitfield HN, Fry IK, Hendry WF, Wickham JEA: Obstructive nephropathy: Successful evaluation with radionuclides.Lancet 1:905–906, 1979
Tveter KJ, Nerdrum HJ, Mjolnerod OK: The value of radioisotope renography in the follow-up of patients operated upon for hydronephrosis.J Urol 114:680, 1975
Dubovsky EV,et al.: Comprehensive evaluation of renal function in the transplanted kidney.J Nucl Med 16:1115, 1975
Whitfield HN,et al.: Furosemide intravenous urography in the diagnosis of pelvic-ureteric junction obstruction.Br J Urol 51:445, 1979
Roedler HD, Kaul A, Hine GJ:Internal Radiation Dose in Diagnostic Nuclear Medicine. Berlin: Verlag H. Hoffman, 1978
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sanger, J.J., Lipcon Kramer, E. Radionuclide quantitation of renal function. Urol Radiol 14, 69–78 (1992). https://doi.org/10.1007/BF02926907
Issue Date:
DOI: https://doi.org/10.1007/BF02926907